The Injury of Intestinal Tract Induced by the NSAIDs

Abstract

Abstract: Non steroidal-anti-inflammatory drugs(NSAIDs) is the clinical application of the most widely prescribed drugs the most common one, but the therapeutic effects of these drugs and adverse reactions exist, inappropriate application or abuse, would cause serious harm to patients. Numerous studies show that NSAIDs not only cause damage to the stomach can also cause intestinal damage, and even more serious than the upper digestive tract, should alert the clinicians.

Key words: NSAIDs, small intestinal injury, pathogenesis, treatment

CLC Number:

R916.63

LUO Jia, WANG Hui-Ji, HAO Rui-rui. The Injury of Intestinal Tract Induced by the NSAIDs[J]. Chinese Journal of Pharmacovigilance, 2011, 8(5): 302-305.

References

[1] Douthwaite AH,Lintott SAM. Gastroscopic observations of the effect of aspirin. and certain other substances on the stomach[J]. Lancet,1938,2:1222-1225.
[2] Kazuhide Higuchi, Eiji Umegaki. Present status and strategy of NSAIDs-induced small bowel injury[J].Gastroenterol,2009,44:879-888.
[3] Angi A, Lakatos L. Adverse effects of non-steroidal anti-inflammatory drugs in the lowergastrointestinal tract[J].Orv Hetil, 2009 150(1):27-34.
[4] AngelLanas,M D, DSc*, FedericoSopea,et al.Nonsteroidal Anti-Inflammatory Drugs and Lower Gastrointestinal[J]. Gastroenterol Clin N Am, 38(2009):333-352.
[5] Kim J W. NSAID-induced gastroenteropathy[J]. Korean J Gastroe-nterol, 2008,52(3):134-41.
[6] Gérard Thiéfin a, Laurent Beaugerie. Toxic effects of nonsteroidal antiinflammatory drugs on the small bowel,colon, and rectum[J]. Joint Bone Spine,2005,72:286-294.
[7] Anthony A, Pounder R E, Dhillon A P, et al. Vascular anatomy defines sites of indomethacin induced jejunal ulceration along the mesenteric margin[J].Gut,1997,41:763-770.
[8] Bjarnason I, Zanelli G, Smith T, et al. Non-steroidal anti-inflammatory drug induced intestinal inflammation in humans[J]. Gastro-enterology,1987,93:480-489.
[9] 戴冽.非甾体抗炎药的胃肠损害及其防治[J].中国药物与临床.2002,2(1)：33-35.
[10] Allison M C, Allan G, Howatson A G, et al. Gastrointestinal damage associated with the use of non-steroidal anti-inflammatory drugs[J]. N Engl J Med,1992,327:749-754.
[11] Remes-Troche J M, Contreras-Zurita K, Rios-Luna N P, et al. Colonic stenosis secondary to non-steroid anti-inflammatory agents as a cause of anemia and chronic diarrhea[J].Rev Gastroenterol Mex,2002,67(4):271-5.
[12] Katsinelos P, Christodoulou K, Pilpilidis I, et al. Colopathy associated with the systemic use of nonsteroidal antiinflammatory medications. An underestimated entity[J]. Hepatogastroenterology, 2002,49(44):345-8.
[13] Kent T H, Cardelli R M, Stamler F W. Small intestinal ulcers and intestinal flora in rats given indomethacin[J]. Am J Pathol,1969,54:237-245.
（因版面有限,部分参考文献省略,如有需要,请联系编辑部）

[1]	JIANG Wenshuo, YANG Li. Adverse drug reaction among 694 patients in an epilepsy physician-pharmacist joint clinic [J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 102-106.
[2]	FAN Xiucong, DONG Xiaohui, CHEN Danxia, BAO Siwei, MA Yabin. Pharmaceutical care of a patient with Clostridium difficile infection and urinary tract infection during pregnancy [J]. Chinese Journal of Pharmacovigilance, 2023, 20(5): 579-582.
[3]	LI Meng, LI Rongrong, LIU Chenghai. Clinic diagnosis and treatment of herb-induced liver injury [J]. Chinese Journal of Pharmacovigilance, 2023, 20(2): 127-131.
[4]	GAO Jing, ZHANG Zhuo, YAN Jiayi, GE Yunxuan, MA Zengchun, GAO Yue. Evaluation of animal models of high altitude qi deficiency and blood stasis syndrome and research progress in therapeutic drugs [J]. Chinese Journal of Pharmacovigilance, 2023, 20(10): 1189-1194.
[5]	YUAN Xiaolong, WAN Qihua, TAO Donghong, QI Hao, WANG Aixia. Pharmaceutical care of a severely poisoned patient with methotrexate tablets [J]. Chinese Journal of Pharmacovigilance, 2022, 19(8): 924-928.
[6]	ZHU Jinying, ZHOU Sufeng, WANG Lu, XU Mingzhe, SHAO Feng. Advances in pediatric drug for central sedation based on pharmacokinetic/pharmacodynamic modeling and simulation [J]. Chinese Journal of Pharmacovigilance, 2022, 19(7): 721-727.
[7]	WEI Xianni, XU Huiyi, HUANG Yuhong, XIE Genying. Influencing factors and treatment of drug-induced liver injury [J]. Chinese Journal of Pharmacovigilance, 2022, 19(6): 665-669.
[8]	SU Xinxin, LI Lixun, WANG Zhifei, XIE Yanming, WANG Qi. Real-world study on Xiyanping injection combined in the treatment of childhood pneumonia [J]. Chinese Journal of Pharmacovigilance, 2022, 19(1): 47-51.
[9]	MA Yini, ZHANG Lixiang, ZHANG Zhetao, WANG Xiaoyu, SHI Tianlu. Adverse Drug Reactions of Anti-thyroid Drugs and Effects of ¹³¹I Replacement Therapy in Patients with Hyperthyroidism [J]. Chinese Journal of Pharmacovigilance, 2021, 18(5): 469-472.
[10]	ZHAO Ronghua, GUO Shanshan, SUN Jing, SHI Yujing, BAO Lei, GENG Zihan, BAO Yanyan, Zhou Guanru, GAO Yingjie, CUI Xiaolan, WANG Daohan. The Mechanism of Cultured Bezoar against the Epidemic Model of Human Coronavirus Pneumonia [J]. Chinese Journal of Pharmacovigilance, 2021, 18(12): 1117-1122.
[11]	FAN Yan, WANG Dan, WANG Chunting. The Mechanism of Toxicity Reaction Induced by Protamine Sulfate Injection [J]. Chinese Journal of Pharmacovigilance, 2021, 18(12): 1159-1161.
[12]	ZHANG Xiaowen, HOU Wenbin, YANG Ming, LIU Jianping. Opportunities and Challenges of Pharmacovigilance in Cancer Treatment [J]. Chinese Journal of Pharmacovigilance, 2021, 18(11): 1034-1038.
[13]	ZHENG Xue, SI Jigang. Research Progress of Weight Gain Induced by Antidepressants [J]. Chinese Journal of Pharmacovigilance, 2020, 17(7): 444-447.
[14]	TIAN Di, WANG Lin, GE Ziruo, CUI Shuping, CHEN Zhihai. Present Situation and Prospect of Antiviral Treatments for COVID-19 [J]. Chinese Journal of Pharmacovigilance, 2020, 17(3): 129-135.
[15]	CHEN Chong, GE Ziruo, WANG Lin, CHEN Zhihai. Analysis and Prospect of Domestic and Foreign Plague Antibacterial Treatment Plan [J]. Chinese Journal of Pharmacovigilance, 2020, 17(1): 1-5.